Pancreatic Cancer Research

ResearcherHokkaido UniversityActive in the last 2 years

Shintaro Takeuchi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7299-2342; OpenAlex author ID A5031482885, A5105193521. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
41
Papers, trials and grants by year

2015: 2 papers · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 7

  1. Duke Pancreatic Monoclonal Antigen Type 2 for Monitoring Carbohydrate Antigen 19-9 Nonexpressor Pancreatic Cancer. Co-author DOI 10.1001/jamasurg.2026.1810↗
  2. Co-targeting an AMPK–MAPK axis reprograms fibroblasts and suppresses PDAC Co-author DOI 10.64898/2026.03.16.711738↗
  3. Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer. Co-author DOI 10.1038/s41417-018-0020-7↗
  4. Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation. Co-author DOI 10.18632/oncotarget.21939↗
  5. Clinical impact of chemotherapy to improve tumor microenvironment of pancreatic cancer. First author DOI 10.4251/wjgo.v8.i11.786↗
  6. Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Canc… Co-author DOI 10.1158/0008-5472.can-14-2921↗
  7. Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice. Co-author DOI 10.18632/oncotarget.5729↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Satoshi Hirano · 7 shared papers, 2015–2026 · strength 0.67
  2. Takahiro Tsuchikawa · 5 shared papers, 2015–2018 · strength 0.28
  3. Toru Nakamura · 5 shared papers, 2015–2018 · strength 0.28
  4. Toshiaki Shichinohe · 4 shared papers, 2015–2018 · strength 0.23
  5. Hironobu Takano · 4 shared papers, 2015–2018 · strength 0.20
  6. Kazuho Inoko · 4 shared papers, 2015–2018 · strength 0.20
  7. Yosuke Inoue · 1 shared paper, 2026 · strength 0.20
  8. So Yamaki · 1 shared paper, 2026 · strength 0.20
  9. Sohei Satoi · 1 shared paper, 2026 · strength 0.20
  10. Teiichi Sugiura · 1 shared paper, 2026 · strength 0.20
  11. Kenjiro Okada · 1 shared paper, 2026 · strength 0.20
  12. Ryuta Shintakuya · 1 shared paper, 2026 · strength 0.20
  13. Masamichi Mizuma · 1 shared paper, 2026 · strength 0.20
  14. Atsushi Oba · 1 shared paper, 2026 · strength 0.20
  15. Kojiro Omiya · 1 shared paper, 2026 · strength 0.20
  16. Daisuke Hashimoto · 1 shared paper, 2026 · strength 0.20
  17. Kenichiro Uemura · 1 shared paper, 2026 · strength 0.20
  18. Daisuke Ban · 1 shared paper, 2026 · strength 0.20
  19. Katsuhisa Ohgi · 1 shared paper, 2026 · strength 0.20
  20. Nobuhiko Nakagawa · 1 shared paper, 2026 · strength 0.20
  21. Koetsu Inoue · 1 shared paper, 2026 · strength 0.20
  22. Michiaki Unno · 1 shared paper, 2026 · strength 0.20
  23. Fuyuhiko Motoi · 1 shared paper, 2026 · strength 0.20
  24. Kazuaki Harada · 1 shared paper, 2026 · strength 0.18
  25. Sho Sekiya · 1 shared paper, 2026 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.